Mer­ck to with­draw dan­gling ac­cel­er­at­ed ap­proval for Keytru­da in third-line stom­ach can­cer

In a first for the dan­gling ac­cel­er­at­ed ap­provals re­viewed by FDA’s on­col­o­gy ad­comm in April, Mer­ck on Thurs­day af­ter­noon agreed to pull a third-line stom­ach …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.